162 related articles for article (PubMed ID: 12478110)
1. Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumor.
Retz M; Lehmann J; Amann E; Wullich B; Röder C; Stöckle M
J Urol; 2003 Jan; 169(1):86-9. PubMed ID: 12478110
[TBL] [Abstract][Full Text] [Related]
2. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor.
Okegawa T; Kinjo M; Horie S; Nutahara K; Higashihara E
Urology; 2003 Jul; 62(1):182-6. PubMed ID: 12837463
[TBL] [Abstract][Full Text] [Related]
3. The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine.
Pu XY; Wang ZP; Chen YR; Wang XH; Wu YL; Wang HP
J Cancer Res Clin Oncol; 2008 Jun; 134(6):659-65. PubMed ID: 18026991
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
[TBL] [Abstract][Full Text] [Related]
5. Urinary cytokeratin 20 as a marker for transitional cell carcinoma.
Rotem D; Cassel A; Lindenfeld N; Mecz Y; Sova Y; Resnick M; Stein A
Eur Urol; 2000 May; 37(5):601-4. PubMed ID: 10765100
[TBL] [Abstract][Full Text] [Related]
6. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
7. Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells.
Inoue T; Nakanishi H; Inada K; Hioki T; Tatematsu M; Sugimura Y
J Urol; 2001 Dec; 166(6):2134-41. PubMed ID: 11696722
[TBL] [Abstract][Full Text] [Related]
8. Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma.
Retz M; Lehmann J; Röder C; Plötz B; Harder J; Eggers J; Pauluschke J; Kalthoff H; Stöckle M
Cancer Res; 1998 Dec; 58(24):5662-6. PubMed ID: 9865718
[TBL] [Abstract][Full Text] [Related]
9. Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.
Eissa S; Kassim SK; Labib RA; El-Khouly IM; Ghaffer TM; Sadek M; Razek OA; El-Ahmady O
Cancer; 2005 Apr; 103(7):1356-62. PubMed ID: 15717321
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
11. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
12. Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer.
Golijanin D; Shapiro A; Pode D
J Urol; 2000 Dec; 164(6):1922-5. PubMed ID: 11061882
[TBL] [Abstract][Full Text] [Related]
13. Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR.
Retz M; Lehmann J; Szysnik C; Zwank S; Venzke T; Röder C; Kalthoff H; Basbaum C; Stöckle M
Eur Urol; 2004 Mar; 45(3):314-9. PubMed ID: 15036676
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.
Retz M; Lehmann J; Röder C; Weichert-Jacobsen K; Loch T; Romahn E; Lühl C; Kalthoff H; Stöckle M
Eur Urol; 2001 May; 39(5):507-15; discussion 516-7. PubMed ID: 11464030
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma.
Eissa S; Kenawy G; Swellam M; El-Fadle AA; Abd El-Aal AA; El-Ahmady O
Clin Biochem; 2004 Sep; 37(9):803-10. PubMed ID: 15329320
[TBL] [Abstract][Full Text] [Related]
16. Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer.
Isurugi K; Suzuki Y; Tanji S; Fujioka T
J Urol; 2002 Oct; 168(4 Pt 1):1574-7. PubMed ID: 12352460
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients.
Kinjo M; Okegawa T; Horie S; Nutahara K; Higashihara E
Int J Urol; 2004 Jan; 11(1):38-43. PubMed ID: 14678183
[TBL] [Abstract][Full Text] [Related]
18. The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.
Eissa S; Badr S; Elhamid SA; Helmy AS; Nour M; Esmat M
Dis Markers; 2013; 34(1):57-62. PubMed ID: 22960341
[TBL] [Abstract][Full Text] [Related]
19. Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction.
Fujii Y; Kageyama Y; Kawakami S; Kihara K; Oshima H
Jpn J Cancer Res; 1999 Jul; 90(7):753-7. PubMed ID: 10470288
[TBL] [Abstract][Full Text] [Related]
20. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.
Melissourgos N; Kastrinakis NG; Davilas I; Foukas P; Farmakis A; Lykourinas M
Urology; 2003 Aug; 62(2):362-7. PubMed ID: 12893365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
